Neutralising antibodies to interferon-β in the treatment of multiple sclerosis: Cause for concern?

Subscribe to email list

Please select the email list(s) to which you wish to subscribe.

You are here

Neutralising antibodies to interferon-β in the treatment of multiple sclerosis: Cause for concern?

TitleNeutralising antibodies to interferon-β in the treatment of multiple sclerosis: Cause for concern?
Publication TypeJournal Article
Year of Publication1999
AuthorsPaszner, B, Petkau, J, Oger, J
JournalCNS Drugs
Volume11
Pagination225–243